Patrick M. Glassman

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier

Oscar A. Marcos‐Contreras, Colin F. Greineder, Raisa Y. Kiseleva et al. · Proceedings of the National Academy of Sciences · 2020 · 180 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation

Jacob W. Myerson, Priyal Patel, Kathryn M. Rubey et al. · Nature Nanotechnology · 2021 · 116 citations · Full text

Life Sciences, Biochemistry, Immunology +16

Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles

Jacob W. Myerson, Bruce Braender, Olivia Mcpherson et al. · Advanced Materials · 2018 · 101 citations

Pharmacy, Bioengineering, Pharmaceutics +17

Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies

Patrick M. Glassman, Joseph P. Balthasar · Journal of Pharmacokinetics and Pharmacodynamics · 2016 · 88 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke

Jia Nong, Patrick M. Glassman, Vladimir V. Shuvaev et al. · Molecular Therapy · 2024 · 83 citations · Full text

Pharmacy, Neuroscience, Pharmaceutics +16